Jpmorgan Chase & CO Prokidney Corp Ord Shs Cl A(Cy Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Jpmorgan Chase & CO holds 66,415 shares of PROK stock, worth $65,086. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,415
Previous 46,830
41.82%
Holding current value
$65,086
Previous $89,000
25.84%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PROK
# of Institutions
74Shares Held
47.5MCall Options Held
100KPut Options Held
16.4K-
Morgan Stanley New York, NY14MShares$13.7 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$12.1 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.28MShares$5.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$3.58 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.23MShares$2.19 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $60.3M